Aptus Capital Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
Aptus Capital Advisors's LH Position: Q2 2026 in Review
Aptus Capital Advisors increased its Labcorp (LH) stake by 1.9% in Q2 2026, buying an estimated $11K and bringing the position to 2,241 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #729.
Aptus Capital Advisors first reported a position in LH in Q1 2021 and has held it in 22 quarters since. The position peaked at $949K in Q3 2022. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Aptus Capital Advisors held 2,241 shares of Labcorp worth $627K as of Q2 2026.
- Aptus Capital Advisors bought 42 Labcorp shares in Q2 2026, an estimated $11K.
- Labcorp made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #729 holding.
- Aptus Capital Advisors first reported a position in Labcorp in Q1 2021 and has held it in 22 quarters since.
- Aptus Capital Advisors's Labcorp position peaked at $949K in Q3 2022.
- 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.